{"id":"W2017088119","doi":"10.1111/cen.12431","title":"Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase <scp>III</scp> study","year":2014,"lang":"en","type":"article","venue":"Clinical Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Viropharma; Massachusetts General Hospital; Novartis Pharmaceuticals Corporation; Novartis; Pfizer","keywords":"Pasireotide; Medicine; Cushing's disease; Internal medicine; Adverse effect; Randomization; Blood pressure; Gastroenterology; Octreotide; Somatostatin; Disease; Endocrinology; Acromegaly; Clinical trial; Hormone; Growth hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003046898,0.0004246795,0.001289218,0.0001218246,0.00009205229,0.00002532969,0.0001500889,0.0001547617,0.000007786309],"category_scores_gemma":[0.002361308,0.0002771346,0.0001944513,0.0001294454,0.0004265844,0.00009236982,0.000110967,0.0004061254,0.00003474957],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005167665,"about_ca_system_score_gemma":0.0001447467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005568835,"about_ca_topic_score_gemma":0.0003180014,"domain_scores_codex":[0.9957972,0.0005849564,0.001448614,0.001255535,0.000253212,0.0006605459],"domain_scores_gemma":[0.9945943,0.003446882,0.0003891385,0.0007826281,0.00007810216,0.0007089406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006054285,0.02370074,0.8963209,0.000006736345,0.0006062963,0.0005235921,0.0001892173,0.000001137642,0.000002788792,0.0000299785,0.0001407635,0.07242355],"study_design_scores_gemma":[0.1287137,0.04483479,0.8234814,0.00004184466,0.0006868443,0.000002701429,0.0002291899,0.0001114461,0.00000584119,0.0002518454,0.001519925,0.000120449],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967125,0.0002446844,0.00003502928,0.0003107174,0.000306503,0.001659046,0.0002141336,0.00009156597,0.0004258047],"genre_scores_gemma":[0.9980073,0.0002201529,0.000136527,0.0004941758,0.0002365283,0.0001093683,0.0005149529,0.00003818169,0.0002428239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1226594,"threshold_uncertainty_score":0.9999681,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03250574179261949,"score_gpt":0.3471564826596509,"score_spread":0.3146507408670314,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}